ID

23704

Description

The Clinical and Economic Impact of Pharmacogenomic Testing for Tamoxifen Metabolism in Postmenopausal Women Receiving Tamoxifen for Prevention of Recurrent Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00830973

Link

https://clinicaltrials.gov/show/NCT00830973

Keywords

  1. 7/11/17 7/11/17 -
Uploaded on

July 11, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Breast Neoplasms NCT00830973

Eligibility Breast Neoplasms NCT00830973

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patient currently has a pharmacy benefit with medco for an enrolled client
Description

Pharmacy Benefit Clinical trial participant

Data type

boolean

Alias
UMLS CUI [1,1]
C0031322
UMLS CUI [1,2]
C0010187
UMLS CUI [1,3]
C1997894
patient has a adjudicated tamoxifen pharmacy claims within the last six months
Description

Tamoxifen | Insurance, Pharmaceutical Services

Data type

boolean

Alias
UMLS CUI [1]
C0039286
UMLS CUI [2]
C0021691
patient is still taking tamoxifen to prevent recurrent breast cancer
Description

Tamoxifen | Prevention Breast cancer recurrent

Data type

boolean

Alias
UMLS CUI [1]
C0039286
UMLS CUI [2,1]
C2700409
UMLS CUI [2,2]
C0278493
patient is a natural postmenopausal women 50 years of age or older
Description

Postmenopausal state | Age

Data type

boolean

Alias
UMLS CUI [1]
C0232970
UMLS CUI [2]
C0001779
patient signs consent
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
patient is willing to provide sample for genetic testing
Description

Sample Provide Genetic testing

Data type

boolean

Alias
UMLS CUI [1,1]
C0370003
UMLS CUI [1,2]
C1999230
UMLS CUI [1,3]
C0679560
physician managing tamoxifen therapy is willing to order pharmacogenetic test
Description

Tamoxifen | Pharmacogenetic Test Willing

Data type

boolean

Alias
UMLS CUI [1]
C0039286
UMLS CUI [2,1]
C2347500
UMLS CUI [2,2]
C0600109
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patient is male
Description

Gender

Data type

boolean

Alias
UMLS CUI [1]
C0079399
patient is under 50 years old
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
patient has previous history of cyp450 2d6 testing
Description

Cytochrome P-450 2D6 Testing

Data type

boolean

Alias
UMLS CUI [1,1]
C0057223
UMLS CUI [1,2]
C0039593
patient is no longer taking tamoxifen
Description

Tamoxifen Discontinued

Data type

boolean

Alias
UMLS CUI [1,1]
C0039286
UMLS CUI [1,2]
C1444662
patient refuses to sign consent
Description

Informed Consent Refused

Data type

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C1705116
patient wishes to no longer participate after testing
Description

Participation Continue Unwilling | Testing Status post

Data type

boolean

Alias
UMLS CUI [1,1]
C0679823
UMLS CUI [1,2]
C0549178
UMLS CUI [1,3]
C0558080
UMLS CUI [2,1]
C0039593
UMLS CUI [2,2]
C0231290
patient's physician refuses to order pharmacogenetic test
Description

Pharmacogenetic Test Refused

Data type

boolean

Alias
UMLS CUI [1,1]
C2347500
UMLS CUI [1,2]
C1705116

Similar models

Eligibility Breast Neoplasms NCT00830973

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Pharmacy Benefit Clinical trial participant
Item
patient currently has a pharmacy benefit with medco for an enrolled client
boolean
C0031322 (UMLS CUI [1,1])
C0010187 (UMLS CUI [1,2])
C1997894 (UMLS CUI [1,3])
Tamoxifen | Insurance, Pharmaceutical Services
Item
patient has a adjudicated tamoxifen pharmacy claims within the last six months
boolean
C0039286 (UMLS CUI [1])
C0021691 (UMLS CUI [2])
Tamoxifen | Prevention Breast cancer recurrent
Item
patient is still taking tamoxifen to prevent recurrent breast cancer
boolean
C0039286 (UMLS CUI [1])
C2700409 (UMLS CUI [2,1])
C0278493 (UMLS CUI [2,2])
Postmenopausal state | Age
Item
patient is a natural postmenopausal women 50 years of age or older
boolean
C0232970 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Informed Consent
Item
patient signs consent
boolean
C0021430 (UMLS CUI [1])
Sample Provide Genetic testing
Item
patient is willing to provide sample for genetic testing
boolean
C0370003 (UMLS CUI [1,1])
C1999230 (UMLS CUI [1,2])
C0679560 (UMLS CUI [1,3])
Tamoxifen | Pharmacogenetic Test Willing
Item
physician managing tamoxifen therapy is willing to order pharmacogenetic test
boolean
C0039286 (UMLS CUI [1])
C2347500 (UMLS CUI [2,1])
C0600109 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Gender
Item
patient is male
boolean
C0079399 (UMLS CUI [1])
Age
Item
patient is under 50 years old
boolean
C0001779 (UMLS CUI [1])
Cytochrome P-450 2D6 Testing
Item
patient has previous history of cyp450 2d6 testing
boolean
C0057223 (UMLS CUI [1,1])
C0039593 (UMLS CUI [1,2])
Tamoxifen Discontinued
Item
patient is no longer taking tamoxifen
boolean
C0039286 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
Informed Consent Refused
Item
patient refuses to sign consent
boolean
C0021430 (UMLS CUI [1,1])
C1705116 (UMLS CUI [1,2])
Participation Continue Unwilling | Testing Status post
Item
patient wishes to no longer participate after testing
boolean
C0679823 (UMLS CUI [1,1])
C0549178 (UMLS CUI [1,2])
C0558080 (UMLS CUI [1,3])
C0039593 (UMLS CUI [2,1])
C0231290 (UMLS CUI [2,2])
Pharmacogenetic Test Refused
Item
patient's physician refuses to order pharmacogenetic test
boolean
C2347500 (UMLS CUI [1,1])
C1705116 (UMLS CUI [1,2])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial